| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/15/2008 | WO2008035359A3 Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives |
| 05/15/2008 | WO2008033464A3 Azetidinone derivatives for the treatment of disorders of the lipid metabolism |
| 05/15/2008 | WO2008028928A8 Novel combination of agents for the treatment of hiv-associated adipose redistribution syndrome (hars) |
| 05/15/2008 | WO2008006969A3 Novel tetracyclic derivatives, process for the preparation thereof and pharmaceutical compositions which contain them |
| 05/15/2008 | WO2007126792A3 Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases |
| 05/15/2008 | US20080114065 Conjugated fatty acid or alcohol, thiol-containing compound and bioavailable form of trivalent chromium; preventing metabolic dysregulation of adipocytes resulting from HIV-1 infection or chronic inflammation |
| 05/15/2008 | US20080114044 Isoxazole compounds as Peroxisome Proliferator-Activated Receptor (PPAR) delta modulators; (5-{4-[2-(2,4-Dichloro-phenoxy)-ethyl-carbamoyl]-5-phenyl-isoxazol-3-yl}-phenyl)-acetic acid; diabetes, cardiovascular disorders, dyslipidemias, irritable bowel disease, cancer, skin disorders, eye disorders |
| 05/15/2008 | US20080114042 Compound |
| 05/15/2008 | US20080114034 ethyl 1-benzyl-5-(3-carboxypropoxy)-2-methyl-6-pyrid-3-yl-1H-indole-3-carboxylate; peroxisome proliferator activated receptors agonist; dyslipidaemia, atherosclerosis, diabetes, obesity; high level lipoprotein controllong |
| 05/15/2008 | US20080114031 1,2;5,6-Di-O-isopropylidene-3-deoxy-3-[{(4-chloro-phenyl)amino}-carbonyl]-amino- alpha -D-allofuranoside; |
| 05/15/2008 | US20080114018 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/15/2008 | US20080113997 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor |
| 05/15/2008 | US20080113985 Modulators of ATP-binding cassette transporters |
| 05/15/2008 | US20080113982 Azacyclosteroid histamine-3 receptor ligands |
| 05/15/2008 | US20080113968 Substituted piperazines and diazepanes |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113905 Biologically active peptide with extended half-life and a slower clearance compared to unPEGylated peptide; PEGylated GLP-1 compounds treat diabetes, obesity, irritable bowel syndrome |
| 05/15/2008 | US20080113903 Prevent mammals tissue injuries |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080112948 Water-soluble globulin concentrate for improving growth in animals |
| 05/15/2008 | US20080112918 Method for treating gout and binding uric acid |
| 05/15/2008 | DE102006053637A1 Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted with fluorine 1,4-benzothiepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | DE102006053636A1 Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New-substituted 1,4-cyclohexyl-1,1-dioxide derivatives benzothiepine, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | DE102006053635A1 Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted benzyl 1,4-benzothiepine-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | CA2672956A1 Calcium receptor modulating agents |
| 05/15/2008 | CA2669205A1 Agonist trkb antibodies and uses thereof |
| 05/15/2008 | CA2669043A1 Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions |
| 05/15/2008 | CA2669019A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921094A2 Method for presenting and removing substances |
| 05/14/2008 | EP1921074A1 Thiazole derivative |
| 05/14/2008 | EP1921072A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators |
| 05/14/2008 | EP1921065A1 Phenylpyridone derivative |
| 05/14/2008 | EP1920771A2 Methods of treating hyperlipidemia |
| 05/14/2008 | EP1920769A1 Methods and materials for treating conditions associated with metabolic disorders |
| 05/14/2008 | EP1919869A1 Novel indole compounds |
| 05/14/2008 | EP1919474A1 Pyrrolopyridine derivatives and use of same as ppar receptor modulators |
| 05/14/2008 | EP1919472A1 Compositions and methods for treatment and prevention of hyperuricemia related health consequences |
| 05/14/2008 | EP1919468A2 Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof |
| 05/14/2008 | EP1919465A2 Gsk-3 inhibitors |
| 05/14/2008 | EP1771425B1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 05/14/2008 | EP1664013B1 Calcilytic compounds |
| 05/14/2008 | EP1653934B1 Use of c-kit inhibitors for treating type ii diabetes |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1278540B1 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/14/2008 | EP1274429B1 Topical formulations for the transdermal delivery of niacin prodrugs and methods of treating hyperlipidemia |
| 05/14/2008 | EP1250455B1 Antisense inhibition of ptp1b expression |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | CN101180270A Novel trifluoromethoxy-substituted aryl anilides |
| 05/14/2008 | CN101180073A Insulins combinations |
| 05/14/2008 | CN101180047A Use of cyclodextrin complexes containing lipoic acid |
| 05/14/2008 | CN101177681A Rhabdophis tigrina snake uncoupling protein gene-SB and uses thereof |
| 05/14/2008 | CN101176786A Method and composition for increasing insulin sensibility |
| 05/14/2008 | CN101176772A Pharmaceutical composition made of cattail pollen and safflower |
| 05/14/2008 | CN101176771A Pharmaceutical composition of cattail pollen and pseudo-ginseng |
| 05/14/2008 | CN101176770A Pharmaceutical composition of folium ginkgo and cattail pollen |
| 05/14/2008 | CN101176769A Pharmaceutical composition of cattail pollen and red orpin |
| 05/14/2008 | CN101176760A Usage of prune tree extract |
| 05/14/2008 | CN101176757A Pomegranate leaf extract preparations |
| 05/14/2008 | CN101176751A Pharmaceutical composition of red sage root and cassia twig |
| 05/14/2008 | CN101176741A Hydroxypropyl-beta-cyclodextrin clathrate, preparing method and application of radix bupleuri volatile oil |
| 05/14/2008 | CN101176734A Nutrients replenisher for replenishing folic acid and vitamin B12 and preparation method thereof |
| 05/14/2008 | CN101176727A Policosanol soft capsule and preparation method thereof |
| 05/14/2008 | CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 05/14/2008 | CN100387587C Process for separating purifying actived tea polyphenols |
| 05/14/2008 | CN100387283C Chinese traditional medicine for treating diabetes retinopathy |
| 05/14/2008 | CN100387270C Traditional Chinese medicine formulation for treating and preventing diabetes and its angiopathy |
| 05/14/2008 | CN100387265C Fat-reducing blood-fat-reducing Chinese medicine preparation |
| 05/14/2008 | CN100387258C Liver-nourishing kidney protecting fat lowering tea |
| 05/14/2008 | CN100387126C Method of increasing content of flavonoids and phenolic substances in plants |
| 05/13/2008 | US7371865 Reacting an organophosphouus compound with metallized alkane; forming atorvastatin, lorastatin, pitavastatin, fluvastatin |
| 05/13/2008 | US7371828 Extracellular signal-regulated kinase sequences and methods of production and use |
| 05/13/2008 | US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371767 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371759 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents |
| 05/13/2008 | US7371756 Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371739 Aryl fructose-1,6-bisphosphatase inhibitors |
| 05/13/2008 | US7371730 Crystals of glucopyranosyloxybenzyl benzene derivative |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371576 CD56 positive human adult pancreatic endocrine progenitor cells |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371529 Methods and compositions for modulating gluconeogenesis using PGC-1 |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2263348C Pharmaceutical composition containing 4-oxo-butynic acids |
| 05/13/2008 | CA2255856C Therapeutic uses for an aminosterol compound |
| 05/10/2008 | CA2567621A1 Herbal product comprising cinnamon, bitter melon and omega-3 fatty acids |
| 05/08/2008 | WO2008054211A1 Nutritional products comprising saccharide oligomers |
| 05/08/2008 | WO2008054193A1 Nutritional products that comprise saccharide oligomers |
| 05/08/2008 | WO2008054192A1 Use of nutritional compositions for preventing disorders |
| 05/08/2008 | WO2008053920A1 Physiologically active substance-containing granular composition and method of producing the same |
| 05/08/2008 | WO2008053517A1 Agent for promoting in vivo dha synthesis and seaweed oil |
| 05/08/2008 | WO2008053495A1 A novel crystalline form of atorvastatin sodium |